Training the new generation of researchers on the molecular basis of human enhanceropathies.
Opening new diagnostic and therapeutic avenues for patients. ENHPATHY is a multidisciplinary science consortium created in the frame of the Marie Sklodowska-Curie actions (MSCA)-ITN-ETN European Training Networks call and regrouping 15 academic and 12 non-academic European organisations in the continuum of basic, translational and clinical research on enhancers and associated diseases.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 860002. The information contained in this website reflects only the authors’ view. REA and EC are not responsible for any use that may be made of this information.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 163, Avenue De Luminy, Marseille,provence-Alpes-Cote D'azur 13009,france
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://www.enhpathy.eu/
- Keywords
- Epigenetics.
- HQ
- Marseille, Provence-Alpes-Cote d'Azur
- Competitors
- Klinika Zdybski.
Enhpathy Questions
Enhpathy's website is https://www.enhpathy.eu/
Enhpathy's LinkedIn profile is https://fr.linkedin.com/company/enhpathy
Enhpathy has
1 employees.
View email and phone details for 1
employees at Enhpathy.
Enhpathy's industry is
Research Services
Enhpathy's top competitors are
Klinika Zdybski.
Enhpathy's categories are Research Services
Enhpathy's founding year is 2019
